Scott Robinson, PhD, CQF

Scott Robinson, PhD, CQF is a professional with extensive experience in the financial services industry. Scott began their career in 2006 as a Protein Biochemist at GlaxoSmithKline. In 2011, they joined Capco as an Associate Consultant, where they worked across domains with a focus on finance, risk and compliance. In 2012, they moved to Nomura International as a Risk Analyst and Project Manager. From 2014 to 2015, they worked as a Consultant at HSBC, Credit Suisse and Morgan Stanley, where they held the role of Business Analyst, Consultant and Contractor, respectively. In 2016, they returned to Nomura as a Consultant. In 2021, they joined Vickers Venture Partners as a Venture Principal. Most recently, in 2018, they became President and CSO of MicroQuin.

Scott Robinson, PhD, CQF holds a PhD in Cell and Molecular Biology Research from Imperial College London and a BSc (Hons) in Microbiology with Study in Industry from the University of Bristol. Scott also holds a Certificate in Quantitative Finance.